Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Brivaracetam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB
- 18 Jul 2018 Results assessing pharmacokinetic of brivaracetam (BRV) and its metabolites in subjects with Epilepsy published in European Clinical Trials Database results.
- 05 Dec 2017 Results of pooled analysis from two open-label studies presented at the 71st Annual Meeting of the American Epilepsy Society.
- 09 Mar 2017 Results assessing dosing regimens using population pharmacokinetic model simulations, published in the European Journal of Clinical Pharmacology